Serotypes and antimicrobial susceptibilities of invasive Streptococcus pneumoniae before and after introduction of 7-valent pneumococcal conjugate vaccine, Hong Kong, 1995-2009

Vaccine

Volumn 29, Issue 17, 2011, Pages 3270-3275

  Ho, Pak Leung ^a   Chiu, Susan S ^a   Ang, Irene ^a   Lau, Yu Lung ^a  

^a UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Drug resistance; Heptavalent pneumococcal conjugate vaccine; Serotype replacement; Streptococcus pneumoniae

Indexed keywords

ERYTHROMYCIN; HEPTAVALENT PNEUMOCOCCAL CONJUGATE VACCINE; LEVOFLOXACIN; PENICILLIN G; PNEUMOCOCCUS VACCINE; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AGED; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; CHILD; GROUPS BY AGE; HONG KONG; HUMAN; INVASIVE SPECIES; MAJOR CLINICAL STUDY; MOLECULAR TYPING; NONHUMAN; PNEUMOCOCCAL INFECTION; PNEUMOCOCCAL MENINGITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; SCHOOL CHILD; SEROTYPE; STREPTOCOCCUS PNEUMONIAE; TREND STUDY; VACCINATION;

EID: 79954603483     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.02.025     Document Type: Article

References (27)

1. Hausdorff W.P., Feikin D.R., Klugman K.P. Epidemiological differences among pneumococcal serotypes. Lancet Infect. Dis. 2005, 5:83-93.
2. Pilishvili T., Lexau C., Farley M.M., Hadler J., Harrison L.H., Bennett N.M., et al. Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. J. Infect. Dis. 2010, 201:32-41.
3. Anonymous. Direct and indirect effects of routine vaccination of children with 7-valent pneumococcal conjugate vaccine on incidence of invasive pneumococcal disease-United States, 1998-2003. MMWR Morb Mortal Wkly Rep 2005;54:893-7.
4. Cherian T. WHO expert consultation on serotype composition of pneumococcal conjugate vaccines for use in resource-poor developing countries, 26-27 October 2006, Geneva. Vaccine 2007, 25:6557-6564.
5. Hausdorff W.P., Dagan R., Beckers F., Schuerman L. Estimating the direct impact of new conjugate vaccines against invasive pneumococcal disease. Vaccine 2009, 27:7257-7269.
6. Wyeth Pharmaceuticals HK. Data on file.
7. Centre for Health Protection HK. Inclusion of Pneumococcal Vaccine in Childhood Immunisation Programme. Last accessed 1 February 2010.
8. Ho P.L., Lam K.F., Chow F.K., Lau Y.L., Wong S.S., Cheng S.L., et al. Serotype distribution and antimicrobial resistance patterns of nasopharyngeal and invasive Streptococcus pneumoniae isolates in Hong Kong children. Vaccine 2004, 22:3334-3339.
9. Ho P.L., Que T.L., Chiu S.S., Yung R.W., Ng T.K., Tsang D.N., et al. Fluoroquinolone and other antimicrobial resistance in invasive pneumococci, Hong Kong, 1995-2001. Emerg. Infect. Dis. 2004, 10:1250-1257.
10. Pai R., Gertz R.E., Beall B. Sequential multiplex PCR approach for determining capsular serotypes of Streptococcus pneumoniae isolates. J. Clin. Microbiol. 2006, 44:124-131.
11. Ho P.L., Ang I., Chow K.H., Lai E.L., Chiu S.S. The prevalence and characteristics of Streptococcus pneumoniae isolates expressing serotypes 6C and 6D in Hong Kong prior to the introduction of the 7-valent pneumococcal conjugate vaccine. Diagn. Microbiol. Infect. Dis. 2010, 68:439-444.
12. Ho P.L., Yung R.W., Tsang D.N., Que T.L., Ho M., Seto W.H., et al. Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000. J. Antimicrob. Chemother. 2001, 48:659-665.
13. Ho P.L., Tse W.S., Tsang K.W., Kwok T.K., Ng T.K., Cheng V.C., et al. Risk factors for acquisition of levofloxacin-resistant Streptococcus pneumoniae: a case-control study. Clin. Infect. Dis. 2001, 32:701-707.
14. Clinical and Laboratory Standard Institute. Performance standards for antimicrobial susceptibility testing: twentieth informational supplement. Wayne, Pa: Clinical and Laboratory Standards Institute. 2010; M100-S20.
15. Enright M.C., Spratt B.G. A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 1998, 144:3049-3060.
16. O'Brien K.L., Dagan R. The potential indirect effect of conjugate pneumococcal vaccines. Vaccine 2003, 21:1815-1825.
17. Whitney C.G., Pilishvili T., Farley M.M., Schaffner W., Craig A.S., Lynfield R., et al. Effectiveness of seven-valent pneumococcal conjugate vaccine against invasive pneumococcal disease: a matched case-control study. Lancet 2006, 368:1495-1502.
18. Moore M.R., Gertz R.E., Woodbury R.L., Barkocy-Gallagher G.A., Schaffner W., Lexau C., et al. Population snapshot of emergent Streptococcus pneumoniae serotype 19A in the United States, 2005. J. Infect. Dis. 2008, 197:1016-1027.
19. Reinert R., Jacobs M.R., Kaplan S.L. Pneumococcal disease caused by serotype 19A: review of the literature and implications for future vaccine development. Vaccine 2010, 28:4249-4259.
20. Choi E.H., Kim S.H., Eun B.W., Kim S.J., Kim N.H., Lee J., et al. Streptococcus pneumoniae serotype 19A in children, South Korea. Emerg. Infect. Dis. 2008, 14:275-281.
21. Dagan R., Givon-Lavi N., Leibovitz E., Greenberg D., Porat N. Introduction and proliferation of multidrug-resistant Streptococcus pneumoniae serotype 19A clones that cause acute otitis media in an unvaccinated population. J. Infect. Dis. 2009, 199:776-785.
22. Chiu S.S., Ho P.L., Chow F.K., Yuen K.Y., Lau Y.L. Nasopharyngeal carriage of antimicrobial-resistant Streptococcus pneumoniae among young children attending 79 kindergartens and day care centers in Hong Kong. Antimicrob. Agents Chemother. 2001, 45:2765-2770.
23. Scott J.A., Hall A.J., Dagan R., Dixon J.M., Eykyn S.J., Fenoll A., et al. Serogroup-specific epidemiology of Streptococcus pneumoniae: associations with age, sex, and geography in 7000 episodes of invasive disease. Clin. Infect. Dis. 1996, 22:973-981.
24. American Academy of Pediatrics Committee on Infectious Diseases Recommendations for the prevention of Streptococcus pneumoniae infections in infants and children: use of 13-valent pneumococcal conjugate vaccine (PCV13) and pneumococcal polysaccharide vaccine (PPSV23). Pediatrics 2010, 126:186-190.
25. Chancey R.J., Jhaveri R. Fever without localizing signs in children: a review in the post-Hib and postpneumococcal era. Minerva Pediatr. 2009, 61:489-501.
26. Hausdorff W.P., Siber G., Paradiso P.R. Geographical differences in invasive pneumococcal disease rates and serotype frequency in young children. Lancet 2001, 357:950-952.
27. Ho P.L., Que T.L., Ng T.K., Chiu S.S., Yung R.W., Tsang K.W. Clinical outcomes of bacteremic pneumococcal infections in an area with high resistance. Eur. J. Clin. Microbiol. Infect. Dis. 2006, 25:323-327.